Overview

Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg

Status:
Unknown status

Trial end date:
2013-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the pharmacokinetic characteristics and safety of dilatrend SR capsule 32mg and Dilatrend tablet 25mg in healthy male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Carvedilol